Adenosine triphosphate (ATP) serves as a vital energy currency within human cells. Researchers recently developed advanced chemoproteomic tools to improve ATP-binding protein profiling across the human proteome. These proteins often convert ATP into adenosine diphosphate (ADP) to power essential cellular functions. Therefore, understanding these binding patterns helps scientists identify new therapeutic targets for various diseases. The human proteome contains over 1,500 annotated ATP-binding proteins, many of which are critical in oncology and metabolic medicine.

Advancing ATP-Binding Protein Profiling with New Probes

The research team created specialized ATP and ADP probes featuring a diazirine photoreactive group. This group enables the covalent labeling of proteins upon exposure to light. Additionally, the probes include an alkyne handle, which assists in the imaging and enrichment of the targeted molecules. Furthermore, a unique acid-cleavable linkage connects these functional groups. This design allows researchers to release the nucleotides from the peptides under acidic conditions. Consequently, this innovation significantly improves the accuracy of labeling-site identification during mass spectrometry analysis.

Direct comparative studies showed that the two probes have distinct preferences for different protein families. Specifically, the ADP probe demonstrated more effective labeling of RNA helicases compared to the ATP version. These findings provide deeper insights into how nucleotides interact with their partner proteins. Moreover, this methodology offers a robust framework for studying protein functions in both healthy and diseased states. Scientists can now map the "ATPome" with much higher precision than before. This progress likely accelerates the development of novel drugs targeting kinase-related disorders and other metabolic conditions.

Frequently Asked Questions

What is the benefit of acid-cleavable probes in proteomics?

Acid-cleavable probes allow for the selective release of labels from peptides. This step simplifies the identification of binding sites during mass spectrometry, leading to more precise data regarding protein-ligand interactions.

How does ATP-binding protein profiling impact drug discovery?

Many drug targets, such as kinases, rely on ATP binding. By profiling these sites globally, researchers can identify potential off-target effects and discover new pockets for therapeutic intervention in diseases like cancer.

Why did the researchers study both ATP and ADP probes?

Studying both nucleotides reveals how proteins transition between different binding states. For instance, the ADP probe showed a higher affinity for RNA helicases, which helps clarify the functional mechanisms of these specific enzymes.

Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Gao C et al. Chemoproteomic Profiling of ATP-Binding Sites with Acid-Cleavable Photoreactive Adenosine Phosphate Probes. Anal Chem. 2026 Feb 22. doi: 10.1021/acs.analchem.5c06813. PMID: 41723807.